Organization
Oregon Health and Science University, School of Medicine, Portland, United States of America
1 abstract
Abstract
AN UPDATE ON THE INTEGRATED SAFETY ANALYSIS OF FILGOTINIB IN PATIENTS WITH MODERATE TO SEVERE ACTIVE RHEUMATOID ARTHRITIS OVER A MEDIAN OF 4.3 YEARSOrg: Oregon Health and Science University, School of Medicine, Portland, United States of America, Medical University of Vienna, Department of Medicine III, Division of Rheumatology, Vienna, Austria, University of Milan, Department of Clinical Sciences and Community Health, Milan, Italy, ASST Gaetano Pini-CTO, Department of Rheumatology and Medical Sciences, Milan, Italy, University of Occupational and Environmental Health, Department of Internal Medicine, Kitakyushu, Japan,